[1]
|
Singh, H., Benn, B.S., Jani, C., Abdalla, M. and Kurman, J.S. (2022) Photodynamic Therapy for Treatment of Recurrent Adenocarcinoma of the Lung with Tracheal Oligometastasis. Respiratory Medicine Case Reports, 37, Article ID: 101620. https://doi.org/10.1016/j.rmcr.2022.101620
|
[2]
|
Bao, R., Wang, Y., Lai, J., Zhu, H., Zhao, Y., et al. (2019) En-hancing Anti-PD-1/PD-L1 Immune Checkpoint Inhibitory Cancer Therapy by CD276-Targeted Photodynamic Ablation of Tumor Cells and Tumor Vasculature. Molecular Pharmaceutics, 16, 339-348. https://doi.org/10.1021/acs.molpharmaceut.8b00997
|
[3]
|
Duan, X., Chan, C., Guo, N., Han, W., Weichselbaum, R.R., et al. (2016) Photodynamic Therapy Mediated by Nontoxic Core-Shell Nanoparticles Synergizes with Immune Checkpoint Blockade to Elicit Antitumor Immunity and Antimetastatic Effect on Breast Cancer. Journal of the American Chemical Society, 138, 16686-16695.
https://doi.org/10.1021/jacs.6b09538
|
[4]
|
Hao, K., Lin, L., Sun, P., Hu, Y., Atsushi, M., et al. (2021) Cationic Flexible Organic Framework for Combination of Photodynamic Therapy and Genetic Immunotherapy against Tumors. Small, 17, e2008125.
https://doi.org/10.1002/smll.202008125
|
[5]
|
Liu, Q., Tian, J., Tian, Y., Sun, Q., Sun, D., et al. (2021) Near-Infrared-II Nanoparticles for Cancer Imaging of Immune Checkpoint Programmed Death-Ligand 1 and Photody-namic/Immune Therapy. ACS Nano, 15, 515-525.
https://doi.org/10.1021/acsnano.0c05317
|
[6]
|
Wang, D., Wang, T., Liu, J., Yu, H., Jiao, S., et al. (2016) Ac-id-Activatable Versatile Micelleplexes for PD-L1 Blockade-Enhanced Cancer Photodynamic Immunotherapy. Nano Let-ters, 16, 5503-5513.
https://doi.org/10.1021/acs.nanolett.6b01994
|
[7]
|
Zhou, L., Liang, H., Ge, Y., Ding, W., Chen, Q., et al. (2022) Precisely Targeted Nano-Controller of PD-L1 Level for Non-Small Cell Lung Cancer Spinal Metastasis Immunotherapy. Advanced Healthcare Materials, 11, e2200938.
https://doi.org/10.1002/adhm.202200938
|
[8]
|
Chhatre, S., Murgu, S., Vachani, A. and Jayadevappa, R. (2022) Photodynamic Therapy for Stage I and II Non-Small Cell Lung Cancer: A SEER-Medicare Analysis 2000-2016. Medi-cine, 101, e29053.
https://doi.org/10.1097/MD.0000000000029053
|
[9]
|
Chhatre, S., Vachani, A., Allison, R.R. and Jayadevappa, R. (2021) Survival Outcomes with Photodynamic Therapy, Chemotherapy and Radiation in Patients with Stage III or Stage IV Non-Small Cell Lung Cancer. Cancers, 13, Article No. 803. https://doi.org/10.3390/cancers13040803
|
[10]
|
Yi, E., Chang, J.E., Leem, C., Kim, S. and Jheon, S. (2016) Clinical Results of Photodynamic Therapy in Tracheobronchial Malignancy. Journal of Photochemistry and Photobiology B: Biology, 156, 56-60.
https://doi.org/10.1016/j.jphotobiol.2015.10.009
|
[11]
|
Zhang, Q., Zheng, K., Gu, X., Gao, Y., Zhao, S., et al. (2022) Photodynamic Therapy for Primary Tracheobronchial Malignancy in Northwestern China. Photodiagnosis and Photody-namic Therapy, 37, Article ID: 102701.
https://doi.org/10.1016/j.pdpdt.2021.102701
|
[12]
|
Cramer, G.M., Moon, E.K., Cengel, K.A. and Busch, T.M. (2020) Photodynamic Therapy and Immune Checkpoint Blockade†. Photochemistry and Photobiology, 96, 954-961. https://doi.org/10.1111/php.13300
|
[13]
|
Yuan, Z., Fan, G., Wu, H., Liu, C., Zhan, Y., et al. (2021) Photodynamic Therapy Synergizes with PD-L1 Checkpoint Blockade for Immunotherapy of CRC by Multifunctional Nanoparticles. Molecular Therapy, 29, 2931-2948.
https://doi.org/10.1016/j.ymthe.2021.05.017
|
[14]
|
Austin, J.W., Lu, P., Majumder, P., Ahmed, R. and Boss, J.M. (2014) STAT3, STAT4, NFATc1, and CTCF Regulate PD-1 through Multiple Novel Regulatory Regions in Murine T Cells. The Journal of Immunology, 192, 4876-4886.
https://doi.org/10.4049/jimmunol.1302750
|
[15]
|
Chan, L.-C., Li, C.-W., Xia, W., Hsu, J.-M., Lee, H.-H., et al. (2019) IL-6/JAK1 Pathway Drives PD-L1 Y112 Phosphorylation to Promote Cancer Immune Evasion. Journal of Clin-ical Investigation, 129, 3324-3338.
https://doi.org/10.1172/JCI126022
|
[16]
|
Xiong, W., Qi, L., Jiang, N., Zhao, Q., Chen, L., et al. (2021) Metformin Liposome-Mediated PD-L1 Downregulation for Amplifying the Photodynamic Immunotherapy Efficacy. ACS Applied Materials & Interfaces, 13, 8026-8041.
https://doi.org/10.1021/acsami.0c21743
|
[17]
|
Barsoum, I.B., Smallwood, C.A., Siemens, D.R. and Graham, C.H. (20144) A Mechanism of Hypoxia-Mediated Escape from Adaptive Immunity in Cancer Cells. Cancer Research, 74, 665-674.
https://doi.org/10.1158/0008-5472.CAN-13-0992
|
[18]
|
Corzo, C.A., Condamine, T., Lu, L., Cotter, M.J., Youn, J.I., et al. (2010) HIF-1α Regulates Function and Differentiation of Myeloid-Derived Suppressor Cells in the Tumor Mi-croenvironment. Journal of Experimental Medicine, 207, 2439-2453. https://doi.org/10.1084/jem.20100587
|
[19]
|
Noman, M.Z., Desantis, G., Janji, B., Hasmim, M., Karray, S., et al. (2014) PD-L1 Is a Novel Direct Target of HIF-1α, and Its Blockade under Hypoxia Enhanced MDSC-Mediated T Cell Activation. Journal of Experimental Medicine, 211, 781-790. https://doi.org/10.1084/jem.20131916
|
[20]
|
Zhao, Y., Liu, X., Liu, X., Yu, J., Bai, X., et al. (2022) Combination of Phototherapy with Immune Checkpoint Blockade: Theory and Practice in Cancer. Frontiers in Immunology, 13, Article ID: 955920.
https://doi.org/10.3389/fimmu.2022.955920
|
[21]
|
Wang, X.-Y., Maswikiti, E.P., Zhu, J.-Y., Ma, Y.-L., Zheng, P., et al. (2022) Photodynamic Therapy Combined with Immunotherapy for an Advanced Esophageal Cancer with an Ob-struction Post Metal Stent Implantation: A Case Report and Literature Review. Photodiagnosis and Photodynamic Ther-apy, 37, Article ID: 102671.
https://doi.org/10.1016/j.pdpdt.2021.102671
|
[22]
|
Maller, B., Kaszuba, F. and Tanvetyanon, T. (2019) Complete Tumor Response of Tracheal Squamous Cell Carcinoma after Treatment with Pembrolizumab. The Annals of Thoracic Surgery, 107, e273-e274.
https://doi.org/10.1016/j.athoracsur.2018.08.067
|